Global Adrenocortical Hormones API Market Growth 2023-2029

Global Adrenocortical Hormones API Market Growth 2023-2029

Cortical Hormone, fully called "Adrenal Cortical Hormone", are a group of steroids secreted by adrenal corticosteroids, mainly including glucocorticoids and salt corticosteroids, as well as a small amount of sex hormones, which are important hormones involved in the metabolism of sugar, fat and protein.
LPI (LP Information)' newest research report, the “Adrenocortical Hormones API Industry Forecast” looks at past sales and reviews total world Adrenocortical Hormones API sales in 2022, providing a comprehensive analysis by region and market sector of projected Adrenocortical Hormones API sales for 2023 through 2029. With Adrenocortical Hormones API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Adrenocortical Hormones API industry.
This Insight Report provides a comprehensive analysis of the global Adrenocortical Hormones API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Adrenocortical Hormones API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Adrenocortical Hormones API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Adrenocortical Hormones API and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Adrenocortical Hormones API.
The global Adrenocortical Hormones API market size is projected to grow from US$ 2061.5 million in 2022 to US$ 3232.9 million in 2029; it is expected to grow at a CAGR of 3232.9 from 2023 to 2029.
Leading products represented by Pfizer CentreOne, Sanofi, GlaxoSmithKline, Tianjin Pharmaceutical Group and Xianju Pharma have occupied a leading position in the international market, and the market share of them is over 40% in the global market. The North American market is the most important consumer region, accounting for about 40% of the global total in 2019.Europe is second only to North America, accounting for less than 30% of the global market. The downstream markets for the use of corticosteroid apis are mainly injectable, oral, topical, and inhaled. Among them, oral drugs accounted for the largest proportion, accounting for nearly 50% of the market in 2019.
This report presents a comprehensive overview, market shares, and growth opportunities of Adrenocortical Hormones API market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Prednisone Series
Dexamethasone Series
Betamethasone Series
Hydrocortisone Series
Others
Segmentation by application
Injectable Drugs
Oral Drugs
For External Use Drugs
Inhalation Drugs
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer CentreOne
Sanofi
GlaxoSmithKline
Tianjin Pharmaceutical Group Co., Ltd.
Xianju Pharma
Guangdong VTR Bio-Tech Co., Ltd
Symbiotec Pharmalab
Sun Pharmaceutical
Cipla
Hovione
Shandong Xinhua Pharmaceutical Company Limited
Steroid SpA
Junye Pharmaceutical Co., Ltd.
Avik Pharmaceutical
Great Pacific Exports
Shanghai New Hualian Pharmaceutical Co., Ltd
Shandong Taihua Bio & Tech Stock Co., Ltd
Tianjin Pacific Pharmaceutical Co., Ltd (TJPP)
Teva
Zhejiang Xianju Xianle Pharmaceutical Co., Ltd.
Jiangsu Lianhuan Pharmaceutical Co., Ltd
Shandong Sito Bio-technology CO., LTD

Key Questions Addressed in this Report
What is the 10-year outlook for the global Adrenocortical Hormones API market?
What factors are driving Adrenocortical Hormones API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Adrenocortical Hormones API market opportunities vary by end market size?
How does Adrenocortical Hormones API break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.